Rachid Abaji

Montreal, QC H3T1J4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic Leukemia.

Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic Leukemia.

Journal: Clinical pharmacology and therapeutics

Published: February 06, 2026

Characterization of the impact of the MYBBP1A gene and rs3809849 on asparaginase sensitivity and cellular functions.

Characterization of the impact of the MYBBP1A gene and rs3809849 on asparaginase sensitivity and cellular functions.

Journal: Pharmacogenomics

Published: April 29, 2022

Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.

Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.

Journal: Pharmacogenomics

Published: November 06, 2019

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia.

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: November 08, 2018

Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.

Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.

Journal: Pharmacogenomics

Published: September 08, 2018

Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report.

Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report.

Journal: Haematologica

Published: June 06, 2018

Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response.

Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response.

Journal: Pharmacogenomics and personalized medicine

Published: May 17, 2017

Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.

Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.

Journal: Oncotarget

Published: April 21, 2017

Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic Fibrosis.

Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic Fibrosis.

Journal: Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique

Published: November 07, 2016

Current perspective on pediatric pharmacogenomics.

Current perspective on pediatric pharmacogenomics.

Journal: Expert opinion on drug metabolism & toxicology

Published: January 23, 2016

Topical combinations to treat microvascular dysfunction of chronic postischemia pain.

Topical combinations to treat microvascular dysfunction of chronic postischemia pain.

Journal: Anesthesia and analgesia

Published: March 22, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026